STOCK TITAN
  1. Home
  2. News
  3. BIXT

Bioxytran Inc - BIXT STOCK NEWS

IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Interview at the Emerging Growth Conference
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Announces Positive Phase 2 Trial Results were Featured in “Vaccines” a Peer-Reviewed Journal
clinical trial
IMPACT
SENTIMENT
BIXT : OTC
ProLectin-M Demonstrates Significant Activity Against Influenza and Respiratory Syncytial Virus
IMPACT
SENTIMENT
BIXT : OTC
Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral Drug
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran to Appear on ClearThink IR’s Virtual Live Event
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Interview at the Emerging Growth Conference
IMPACT
SENTIMENT
BIXT : OTC
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
covid-19
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
IMPACT
SENTIMENT
BIXT : OTC
Bioxytran Interview at the Emerging Growth Conference
Stock BIXT logo
Bioxytran Inc

OTC:BIXT

BIXT Rankings

#6962 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

BIXT Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
US
Newton Upper Falls

About BIXT

bioxytran, inc., an early stage pharmaceutical company, focuses on the development, manufacture, and commercialization of various therapeutic drugs to address hypoxia in humans. the company's lead pharmaceutical drug candidate is bxt-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for the treatment of patients with ischemia of the brain resulting from a stroke or the blockage of the blood vessels to the brain. its products also include bxt-252, an injectable anti-necrosis drug to treat a wound that does not heal because limited amount of oxygen reaching the wound. the company was founded in 2017 and is headquartered in newton, massachusetts.